Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
The Fly
Cellectis files $200M mixed securities shelf
17d ago
CLLS
Premium
Ratings
Cautious Hold on Cellectis SA Amid Anticipated Data Releases and Strategic Developments
2M ago
CLLS
Premium
Ratings
Cellectis SA: Hold Rating Amid Stable Financials and Promising Collaborations, Yet Cautious Outlook Due to Market and Clinical Uncertainties
2M ago
CLLS
Premium
The Fly
Cellectis price target lowered to $4 from $5 at Barclays
2M ago
CLLS
Premium
Company Announcements
Cellectis SA Reports Q1 2025 Financial Results
2M ago
Premium
Pre-Earnings
Is CMVLF a Buy, Before Earnings?
2M ago
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
ALT
CLLS
Premium
Company Announcements
Cellectis Reports 2024 Financial Results and Strategic Progress
4M ago
Premium
Ratings
Cellectis SA: Strategic Collaborations and Clinical Advancements Drive Buy Rating
4M ago
CLLS
Premium
Company Announcements
Cellectis Reports 2024 Financial Results and Strategic Advances in CAR T-Cell Therapies
4M ago
Premium
Company Announcements
Cellectis Advances Clinical Programs and Strengthens AstraZeneca Partnership
4M ago
Premium
The Fly
Cellectis reports Q4 EPS (64c) vs (17c) last year
4M ago
AZN
CLLS
Premium
The Fly
Cellectis files to sell 44M ordinary shares for holders
6M ago
CLLS
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
6M ago
BLRX
CLLS
Premium
Company Announcements
Cellectis SA: Financial Growth Amidst Strategic Partnerships
9M ago
Premium
The Fly
Cellectis price target lowered to $5 from $7 at Barclays
9M ago
CLLS
Premium
The Fly
Cellectis reports Q3 EPS (22c), consensus (21c)
9M ago
CLLS
Premium
Pre-Earnings
CMVLF Earnings this Week: How Will it Perform?
9M ago
Premium
The Fly
Cellectis publishes pre-clinical evidence MUC1 CAR T-cells reducing certain BC
11M ago
CLLS
Premium
The Fly
Cellectis granted orphan drug designation for CLLS52
12M ago
CLLS
Premium
The Fly
FDA grants Cellectis’ UCART22 ODD and RPDD status for ALL treatment
12M ago
CLLS
Premium
The Fly
Cellectis treatment of acute lymphoblastic leukemia granted orphan designation
12M ago
CLLS
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
